NGeneBio
HemeaccuTest DNA (108 genes) and RNA (53 genes)
CE-IVD panel for hematological tumors: 108 DNA genes and 53 RNA genes in one test
HEMEaccuTest combines a DNA panel of 108 genes and an RNA panel of 53 genes for comprehensive NGS diagnostics of hematological tumors with CE-IVD certification.
Request a quotationThe kit includes two next-generation sequencing panels: a DNA panel of 108 genes significant in acute leukemia, lymphoma, multiple myeloma and myelodysplastic/myeloproliferative syndromes, and an RNA panel of 53 genes to detect fusion transcripts. The test detects single nucleotide substitutions at an allel frequency of 1-2% and Insertions / deletions - from 2-3%, the result is formed in 2-3 days.
The HEMEaccuTest DNA and RNA panels are CE-IVD certified, and the repeated tests confirm 100% sensitivity and specificity.
Panel coverage
- The DNA panel covers 108 genes significant for acute leukemia, lymphoma, multiple myeloma and MDS/MPN.
- RNA panel includes 53 genes to detect fused transcripts and expression disorders
Analytical characteristics
- Detection of single nucleotide substitutions at an allelic frequency of 1-2%
- Detection of insertions / deletions at an allelic frequency from 2-3%
- 100% sensitivity and specificity in repeated tests
Time limit for implementation
- The result on the panel is formed in 2-3 days
DNA panel
| Parameter | HEMEaccuTest DNA/RNA |
|---|---|
| Genes | 108 (acute leukemia, lymphoma, multiple myeloma, MDS/MPN) |
RNA panel
| Parameter | HEMEaccuTest DNA/RNA |
|---|---|
| Genes | 53 (merged transcripts) |
Analytical characteristics
| Parameter | HEMEaccuTest DNA/RNA |
|---|---|
| SNV sensitivity | from 1-2% allelic frequency |
| Sensitivity of INDEL | from 2-3% allelic frequency |
| Repeatability | 100% sensitivity and specificity |
Term and certification
| Parameter | HEMEaccuTest DNA/RNA |
|---|---|
| Time frame for analysis | 2-3 days |
| Status | CE-IVD |